Contrast-Enhanced MRI Texture Parameters as Potential Prognostic Factors for Primary Central Nervous System Lymphoma Patients Receiving High-Dose Methotrexate-Based Chemotherapy

Contrast Media and Molecular Imaging - Egypt
doi 10.1155/2019/5481491
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Primary Central Nervous System Lymphoma: Implication of High-Dose Chemotherapy Followed by Auto-SCT

Bone Marrow Transplantation
TransplantationHematology
2011English

Correction To: White Matter Changes in Primary Central Nervous System Lymphoma Patients Treated With High-Dose Methotrexate With or Without Rituximab

Journal of Neuro-Oncology
Cancer ResearchOncologyNeurology
2019English

Primary Central Nervous System Lymphoma

Therapeutic Advances in Neurological Disorders
NeurologyPharmacology
2018English

Primary Central Nervous System Lymphoma

Contemporary Neurosurgery
2010English

Primary Central Nervous System Lymphoma

Journal of Neurosurgery
SurgeryNeurology
1985English

Comparison Between Glioblastoma and Primary Central Nervous System Lymphoma Using MR Image-Based Texture Analysis

Magnetic Resonance in Medical Sciences
Nuclear MedicineRadiologyImaging
2018English

High-Dose Chemotherapy With Thiotepa, Busulfan, and Cyclophosphamide and Autologous Stem Cell Transplantation for Patients With Primary Central Nervous System Lymphoma in First Complete Remission

Cancer
Cancer ResearchOncology
2017English

Treatment of Primary Mediastinal Large B Cell Lymphoma With an Alternating Chemotherapy Regimen Based on High-Dose Methotrexate

Annals of Hematology
MedicineHematology
2008English

Central Nervous System Hodgkin Lymphoma Developing During Systemic Chemotherapy

British Journal of Haematology
Hematology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy